4.6 Review

Environmental Neurotoxin β-N-Methylamino-L-alanine (BMAA) as a Widely Occurring Putative Pathogenic Factor in Neurodegenerative Diseases

Journal

MICROORGANISMS
Volume 10, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/microorganisms10122418

Keywords

cyanobacteria; beta-N-methylamino-L-alanine; BMAA; neurodegenerative diseases

Categories

Funding

  1. Science Fund of the Republic of Serbia [7726976]
  2. Ministry of Education, Science and Technological Development of the Republic of Serbia [451-03-68/2022-14/200125, 451-03-68/2022-14/200287]

Ask authors/readers for more resources

In this review, we have discussed the occurrence of beta-N-methylamino-L-alanine (BMAA) and its natural isomers, as well as the detection of the toxin(s) in organisms and sample types. We have also examined the general pathogenic mechanisms of neurodegenerative diseases and how BMAA fits into those mechanisms. Furthermore, we have presented the biogeography of BMAA occurrence, which can contribute to epidemiological research, and analyzed the potential significance of BMAA as well as identified gaps in our understanding. Overall, this review provides a basis for discussing the potential role of BMAA in neurodegenerative diseases, guiding further research, and outlining possible research directions.
In the present review we have discussed the occurrence of beta-N-methylamino-L-alanine (BMAA) and its natural isomers, and the organisms and sample types in which the toxin(s) have been detected. Further, the review discusses general pathogenic mechanisms of neurodegenerative diseases, and how modes of action of BMAA fit in those mechanisms. The biogeography of BMAA occurrence presented here contributes to the planning of epidemiological research based on the geographical distribution of BMAA and human exposure. Analysis of BMAA mechanisms in relation to pathogenic processes of neurodegeneration is used to critically assess the potential significance of the amino acid as well as to identify gaps in our understanding. Taken together, these two approaches provide the basis for the discussion on the potential role of BMAA as a secondary factor in neurodegenerative diseases, the rationale for further research and possible directions the research can take, which are outlined in the conclusions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available